Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 11/2017

01-11-2017 | Short Communication

Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes

Authors: Maria Maddalena D’Errico, Antonio Mangiacotti, Daniele Graziano, Valentina Massa, Pamela Piscitelli, Gianluigi Vendemiale, Francesca Viazzi, Roberto Pontremoli, Aldo Russo, Nicola Marchese, Carlo Vigna, Salvatore De Cosmo

Published in: Acta Diabetologica | Issue 11/2017

Login to get access

Excerpt

Several lines of evidence suggest that increased urinary albumin excretion and reduced glomerular filtration rate (GFR) are independently associated with an increased risk of coronary artery disease (CAD) and mortality in general population as well as in patients with diabetes [1]. It has been recently shown that albuminuria correlates with the presence and severity of coronary atherosclerosis [2] and predicts adverse cardiovascular outcome in patients with CAD [3]. …
Literature
1.
De Cosmo S, Lamacchia O, Pacilli A et al (2014) Normoalbuminuric renal impairment and all-cause mortality in type 2 diabetes mellitus. Acta Diabetol 51(4):687–689CrossRefPubMed
2.
Rein P, Vonbank A, Saely CH et al (2011) Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease. Am J Cardiol 107(8):1144–1148CrossRefPubMed
3.
Kunimura A, Ishii H, Uetani T et al (2016) Prognostic value of albuminuria on cardiovascular outcomes after elective percutaneous coronary intervention. Am J Cardiol 117(5):714–719CrossRefPubMed
4.
Natali A, Boldrini B, Baldi S et al (2014) Impact of mild to moderate reductions of glomerular filtration rate on coronary artery disease severity. Nutr Metab Cardiovasc Dis 24(6):681–688CrossRefPubMed
5.
Hage FG, Venkataraman R, Zoghbi GJ et al (2009) The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 53(23):2129–2140CrossRefPubMed
Metadata
Title
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes
Authors
Maria Maddalena D’Errico
Antonio Mangiacotti
Daniele Graziano
Valentina Massa
Pamela Piscitelli
Gianluigi Vendemiale
Francesca Viazzi
Roberto Pontremoli
Aldo Russo
Nicola Marchese
Carlo Vigna
Salvatore De Cosmo
Publication date
01-11-2017
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 11/2017
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1022-x

Other articles of this Issue 11/2017

Acta Diabetologica 11/2017 Go to the issue

Original Article

Self-care, quality of life and clinical outcomes of type 2 diabetes patients: an observational cross-sectional study

Original Article

Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus

Original Article

Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR

Original Article

Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes

Case Report

Acute esophageal necrosis (black esophagus): a case report and literature review

Erratum

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits